Reducing Alcohol Use to Prevent Cancer Deaths: Estimated Effects Among US Adults

Introduction: The Dietary Guidelines for Americans, 2020 - 2025 recommends non -drinking or no more than 2 drinks for men or 1 drink for women in a day. However, even at lower levels, alcohol use increases the risk for certain cancers. This study estimated mean annual alcohol -attributable cancer deaths and the number of cancer deaths that could potentially be prevented if all U.S. adults who drank in excess of the Dietary Guidelines had instead consumed alcohol to correspond with typical consumption of those who drink within the recommended limits. Methods: Among U.S. residents aged >= 20 years, mean annual alcohol -attributable cancer deaths during 2020 - 2021 that could have been prevented with hypothetical reductions in alcohol use were estimated. Mean daily alcohol consumption prevalence estimates from the 2020 - 2021 Behavioral Risk Factor Surveillance System, adjusted to per capita alcohol sales to address underreporting of drinking, were applied to relative risks to calculate population -attributable fractions for cancers that can occur from drinking alcohol. Analyses were conducted during February - April 2023. Results: In the U.S., an estimated 20,216 cancer deaths were alcohol-attributable/year during 2020 - 2021 (men: 14,562 [72.0%]; women: 5,654 [28.0%]). Approximately 16,800 deaths (83% of alcoholattributable cancer deaths, 2.8% of all cancer deaths) could have been prevented/year if adults who drank alcohol in excess of the Dietary Guidelines had instead reduced their consumption to <= 2 drinks/day for men or <= 1 drink/day for women. Approximately 650 additional deaths could have been prevented annually if men consumed 1 drink/day, instead of 2. Conclusions: Implementing evidence -based alcohol policies (e.g., increasing alcohol taxes, regulating alcohol outlet density) to decrease drinking could reduce alcohol -attributable cancers, complementing clinical interventions. Am J Prev Med 2024;66(4):725 - 729. Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine. This is an open access article under the CC BY -NC -ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).